Jose Luis Bas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jose Luis Bas has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Paloma Bas
Department of Orthopaedics and Traumatology, Hospital Universitari i Politècnic La Fe, Valencia, Spain
3 shared publications - Jorge Mario Morales
Department of Orthopaedics and Traumatology, Hospital Universitari i Politècnic La Fe, Valencia, Spain
2 shared publications - Miquel Bovea
Instituto de Investigación Sanitaria La Fe, València, Spain
2 shared publications - Pedro Rubio
Department of Orthopaedics and Traumatology, Hospital Universitari i Politècnic La Fe, Valencia, Spain
2 shared publications - Silvia Pérez
Department of Orthopaedics and Traumatology, Hospital Universitari i Politècnic La Fe, Valencia, Spain
2 shared publications - Teresa Bas
Hospital Universitari i Politècnic La Fe, Instituto de Investigación Sanitaria IIS La Fe, Av. de Fernando Abril Martorell, 106, Valencia (Valancia), 46026, Spain
2 shared publications
Latest Publications
- Open Access
- 6 April 2026
- Published by Springer Nature in European Spine Journal
- Vol. 35 (10) , 1-10
Quantifying gait and mobility in severe idiopathic scoliosis with inertial measurement technology
Background: Adolescent idiopathic scoliosis (AIS) is the most common spinal deformity in adolescents. Severe curves (> 40°) can alter spinopelvic balance and gait mechanics, although few studies have objectively quantified these effects. To analyze gait characteristics, pelvic mobility, and lumbopelvic motion patterns in patients with severe AIS compared to healthy controls using inertial measurement unit (IMU) technology, and to explore correlations between radiological and gait parameters. Methods: A prospective study was conducted including 35 preoperative AIS patients (Cobb > 40°) and 34 age-matched healthy controls. Each participant underwent gait analysis using a single IMU (BTS G-Sensor) performing three standardized tests: Up and Go , Walk , and 6-Minute Walk . Radiological parameters (Cobb angles, pelvic incidence, tilt, and sacral slope) were recorded through Xray. Statistical comparisons were performed. Results: Among the 35 AIS patients, Lenke type 1 (45.7%) and type 3 (31.4%) curves were the most frequent, with types 2, 4, 5, and 6 observed less commonly. AIS patients showed greater accelerations during standing-up (4.63 ± 1.98 m/s²) and sitting-down (5.12 ± 1.85 m/s²) transitions with reduced trunk flexion (31.00 ± 8.67°) and extension (11.51 ± 8.42º) ranges. They also exhibited significantly lower gait symmetry (92.51 ± 5.01%) and smaller pelvic tilt range (6.33 ± 2.74°). AIS patients have also significantly lower gait speed (1.31 ± 0.10 m/s) and distance walked in the 6-Minute Walk (421.16 ± 65.12 m). Conclusions: Severe AIS alters lumbopelvic rhythm and gait kinematics, producing compensatory patterns characterized by increased pelvic mobility and reduced trunk flexion. IMU-based motion analysis enables objective and reproducible evaluation of these biomechanical changes, offering a valuable clinical tool for preoperative assessment and rehabilitation planning.
- 6 April 2026
- Published by Springer Nature in European Spine Journal
- Vol. 35 (10) , 1-10
Open AccessQuantifying gait and mobility in severe idiopathic scoliosis with inertial measurement technology
Background: Adolescent idiopathic scoliosis (AIS) is the most common spinal deformity in adolescents. Severe curves (> 40°) can alter spinopelvic balance and gait mechanics, although few studies have objectively quantified these effects. To analyze gait characteristics, pelvic mobility, and lumbopelvic motion patterns in patients with severe AIS compared to healthy controls using inertial measurement unit (IMU) technology, and to explore correlations between radiological and gait parameters. Methods: A prospective study was conducted including 35 preoperative AIS patients (Cobb > 40°) and 34 age-matched healthy controls. Each participant underwent gait analysis using a single IMU (BTS G-Sensor) performing three standardized tests: Up and Go , Walk , and 6-Minute Walk . Radiological parameters (Cobb angles, pelvic incidence, tilt, and sacral slope) were recorded through Xray. Statistical comparisons were performed. Results: Among the 35 AIS patients, Lenke type 1 (45.7%) and type 3 (31.4%) curves were the most frequent, with types 2, 4, 5, and 6 observed less commonly. AIS patients showed greater accelerations during standing-up (4.63 ± 1.98 m/s²) and sitting-down (5.12 ± 1.85 m/s²) transitions with reduced trunk flexion (31.00 ± 8.67°) and extension (11.51 ± 8.42º) ranges. They also exhibited significantly lower gait symmetry (92.51 ± 5.01%) and smaller pelvic tilt range (6.33 ± 2.74°). AIS patients have also significantly lower gait speed (1.31 ± 0.10 m/s) and distance walked in the 6-Minute Walk (421.16 ± 65.12 m). Conclusions: Severe AIS alters lumbopelvic rhythm and gait kinematics, producing compensatory patterns characterized by increased pelvic mobility and reduced trunk flexion. IMU-based motion analysis enables objective and reproducible evaluation of these biomechanical changes, offering a valuable clinical tool for preoperative assessment and rehabilitation planning.
- Open Access
Cor-Esc-25: A Low-Cost Prototype for Monitoring Brace Adherence and Pressure in Adolescent Idiopathic Scoliosis
The treatment of adolescent idiopathic scoliosis (AIS) requires the use of orthopedic braces. However, few current designs provide real-time monitoring or inform clinicians about the precise adjustment of therapeutic pressure. The objective of this study is to develop a low-cost open-system prototype capable of providing future researchers with objective information regarding brace adherence and adjustment. For adherence evaluation, a market study was conducted to identify temperature-measuring devices and a custom system was developed to measure adjustment. Cor-Esc-25 was developed to monitor brace adherence using a non-invasive temperature sensor which connects via Bluetooth to the parents’ smartphone, which runs an app that uploads the data to an online platform accessible to clinicians. In addition, a custom-designed pressure sensing device was created. This system uses three patches connected to an acquisition board and are installed on the brace each time the patient visits the clinic. It connects to a customized application where clinicians can view all the information. Cor-Esc-25 represents a first step toward the creation of personalized consultations, where AIS treatment monitoring is based on objective criteria that consider both adherence and brace adjustment. Its design allows for easy integration into clinical settings, thereby improving the ability of researchers and clinicians to assess the effectiveness of brace treatment.
Open AccessCor-Esc-25: A Low-Cost Prototype for Monitoring Brace Adherence and Pressure in Adolescent Idiopathic Scoliosis
The treatment of adolescent idiopathic scoliosis (AIS) requires the use of orthopedic braces. However, few current designs provide real-time monitoring or inform clinicians about the precise adjustment of therapeutic pressure. The objective of this study is to develop a low-cost open-system prototype capable of providing future researchers with objective information regarding brace adherence and adjustment. For adherence evaluation, a market study was conducted to identify temperature-measuring devices and a custom system was developed to measure adjustment. Cor-Esc-25 was developed to monitor brace adherence using a non-invasive temperature sensor which connects via Bluetooth to the parents’ smartphone, which runs an app that uploads the data to an online platform accessible to clinicians. In addition, a custom-designed pressure sensing device was created. This system uses three patches connected to an acquisition board and are installed on the brace each time the patient visits the clinic. It connects to a customized application where clinicians can view all the information. Cor-Esc-25 represents a first step toward the creation of personalized consultations, where AIS treatment monitoring is based on objective criteria that consider both adherence and brace adjustment. Its design allows for easy integration into clinical settings, thereby improving the ability of researchers and clinicians to assess the effectiveness of brace treatment.
- Open Access
- 26 May 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (11) , 3122
Efficacy and Safety of Intravenous Magnesium Sulfate in Spinal Surgery: A Systematic Review and Meta-Analysis
Optimizing pain management in spinal surgery is crucial for preventing adverse events due to delayed mobilization. Magnesium sulfate has potential benefits in spinal surgery because of its analgesic properties and modulation of neurotransmitters and autonomic nervous system. Existing evidence regarding the use of magnesium sulfate is partial and controversial, necessitating a comprehensive meta-analysis to evaluate its efficacy and safety. The aim of this study was to conduct a comprehensive meta-analysis to evaluate the efficacy and safety of magnesium sulfate in spinal surgery compared to other available options. This meta-analysis adhered to the PRISMA guidelines. Patients undergoing spinal surgery were included, with the intervention group receiving intravenous magnesium sulfate (MS) at various doses or combinations, whereas the comparison group received other alternatives or a placebo. The efficacy and safety outcomes were assessed. Data were collected from multiple databases and analyzed using Review Manager version 5.4. Heterogeneity was assessed and fixed- or random-effects models were applied. The meta-analysis included eight studies (n = 541). Magnesium sulfate demonstrated significant reductions in pain at 24 h (MD −0.20, 95% CI: −0.39 to −0.02) and opioid consumption (SMD −0.66, 95% CI: −0.95 to −0.38) compared to placebo. Additionally, a decrease in the use of muscle relaxants (SMD −0.91, 95% CI: −1.65 to −0.17) and remifentanil (SMD −1.52, 95% CI: −1.98 to −1.05) was observed. In contrast, an increase in extubation time (MD 2.42, 95% CI: 1.14 to 3.71) and verbal response (MD 1.85, 95% CI: 1.13 to 2.58) was observed compared to dexmedetomidine. In conclusion, magnesium sulfate administration in spinal surgery reduced pain and opioid consumption, and prolonged orientation and verbal response. No significant differences in blood pressure or heart rate were observed between the groups.
- 26 May 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (11) , 3122
Open AccessEfficacy and Safety of Intravenous Magnesium Sulfate in Spinal Surgery: A Systematic Review and Meta-Analysis
Optimizing pain management in spinal surgery is crucial for preventing adverse events due to delayed mobilization. Magnesium sulfate has potential benefits in spinal surgery because of its analgesic properties and modulation of neurotransmitters and autonomic nervous system. Existing evidence regarding the use of magnesium sulfate is partial and controversial, necessitating a comprehensive meta-analysis to evaluate its efficacy and safety. The aim of this study was to conduct a comprehensive meta-analysis to evaluate the efficacy and safety of magnesium sulfate in spinal surgery compared to other available options. This meta-analysis adhered to the PRISMA guidelines. Patients undergoing spinal surgery were included, with the intervention group receiving intravenous magnesium sulfate (MS) at various doses or combinations, whereas the comparison group received other alternatives or a placebo. The efficacy and safety outcomes were assessed. Data were collected from multiple databases and analyzed using Review Manager version 5.4. Heterogeneity was assessed and fixed- or random-effects models were applied. The meta-analysis included eight studies (n = 541). Magnesium sulfate demonstrated significant reductions in pain at 24 h (MD −0.20, 95% CI: −0.39 to −0.02) and opioid consumption (SMD −0.66, 95% CI: −0.95 to −0.38) compared to placebo. Additionally, a decrease in the use of muscle relaxants (SMD −0.91, 95% CI: −1.65 to −0.17) and remifentanil (SMD −1.52, 95% CI: −1.98 to −1.05) was observed. In contrast, an increase in extubation time (MD 2.42, 95% CI: 1.14 to 3.71) and verbal response (MD 1.85, 95% CI: 1.13 to 2.58) was observed compared to dexmedetomidine. In conclusion, magnesium sulfate administration in spinal surgery reduced pain and opioid consumption, and prolonged orientation and verbal response. No significant differences in blood pressure or heart rate were observed between the groups.